Robert Fox, MD
Neurology · Cleveland, OHNPI 1710915541
Payments from drug & device makers
Across 263 payments — averaging $4889.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$566K
- Janssen Global Services, LLC$328K
- Novartis$133K
- Biogen$101K
- Janssen Research & Development, LLC$20K
- Sanofi US Services Inc.$19K
- plus $119K from 20 others
Across 53 payments — averaging $1021.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$25K
- Sanofi$11K
- Novartis Pharma AG$10K
- Biogen$5K
- F. Hoffmann-la Roche AG$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 72 | $565,582 |
| Janssen Global Services, LLC | 17 | $328,165 |
| Novartis | 11 | $133,041 |
| Biogen | 56 | $101,436 |
| Janssen Research & Development, LLC | 6 | $19,958 |
| Sanofi US Services Inc. | 6 | $18,837 |
| E.r. Squibb & Sons, L.L.C. | 17 | $14,788 |
| TG Therapeutics, Inc. | 15 | $12,060 |
| Bristol Myers Squibb | 5 | $10,744 |
| Novartis Pharma AG | 5 | $9,775 |
| Genentech USA, Inc. | 8 | $9,738 |
| Sanofi-aventis U.S. LLC | 4 | $8,824 |
| Siemens Medical Solutions USA, Inc. | 3 | $7,975 |
| Actelion Pharmaceuticals, Ltd | 4 | $7,676 |
| Roche Diagnostics International Ltd | 4 | $6,860 |
| Greenwich Biosciences, Inc. | 1 | $5,863 |
| F. Hoffmann-la Roche AG | 5 | $5,859 |
| Genentech, Inc. | 8 | $5,403 |
| EMD Serono, Inc. | 7 | $4,874 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $2,625 |
| Pfizer | 1 | $2,375 |
| Johnson & Johnson | 1 | $1,240 |
| Eli Lilly | 1 | $1,088 |
| PTC Therapeutics, Inc. | 1 | $1,050 |
| AstraZeneca | 2 | $141 |
| Eisai Inc. | 1 | $22 |
How this compares
$1,286,000 in reported general payments places this provider in the 95th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Cleveland
- Robert BermelCleveland$6.4M
- Jeffrey CohenCleveland$3.1M
- Yuebing LiCleveland$1.4M
- Devon ConwayCleveland$1.3M
- Glen StevensCleveland$1.1M
- Hubert FernandezCleveland$1.1M
- Hesham AbboudCleveland$1.1M
- Michal GostkowskiCleveland$850K
- Daniel OntanedaCleveland$838K
- Alan LernerCleveland$769K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.